New program offers comprehensive prevention services, screenings, diagnostics and treatment for the number one cause of death and illness in all...
Rutgers Cancer Institute of New Jersey Results Published in JAMA Network Open Newswise — New Brunswick, N.J. – Investigators from Rutgers Cancer Institute of New Jersey, the...
New moms and moms-to-be are invited to visit IEHP's Community Resource Centers in December for free maternal mental health events, which will offer health and wellness...
Today, the U.S. Food and Drug Administration approved Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV infusion for the treatment of patients with unresectable (unable to be removed) or metastatic...